Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 02:22 IST
Sun Pharma arm Dusa files lawsuit against Biofrontera
Source: IRIS | 12 Jul, 2018, 11.01AM
Comments  |  Post Comment

DUSA Pharmaceuticals, Inc., (DUSA) a wholly owned subsidiary of Sun Pharmaceutical Industries announced that DUSA has filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG in the United States District Court for the District of Massachusetts.

The lawsuit alleges patent infringement of DUSA's patents, US 9,723,991 and US 8,216,289 covering DUSA's product, LEVULAN KERASTICK (aminolevulinic acid HCl) for topical solution, 20% used with DUSA's BLU-U Blue Light Photodynamic Therapy Illuminator.

In its amended complaint, DUSA additionally alleges that the Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained confidential DUSA information from former DUSA employees to sell and market defendants' own products. The lawsuit seeks an assessment of both damages and injunctive relief against the Biofrontera defendants.

The patents-in-suit concern an apparatus and method for ''photodynamic therapy'' (or PDT) and equipment for PDT. The photodynamic therapy, pioneered by DUSA, combines a drug with a light source to treat disease conditions. The product was launched by DUSA in September 2000 in the US.

Shares of the company gained Rs 8.2, or 1.46%, to trade at Rs 569.00. The total volume of shares traded was 84,955 at the BSE (10.48 a.m., Thursday).



Sun Pharmaceutical Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Rise in India's crude oil imports, driven by increased consumption: Ind-Ra - 13-Jul-2018 10:44
India's retail sales will cross USD 1.24 trn by 2018: Study - 13-Jul-2018 10:01
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Dilip Buildcon incorporates SPV for Rs 13.13 bn NHAI road project - 12-Jul-2018 15:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
Lupin receives nod for generic Nitrofurantoin capsules - 12-Jul-2018 12:39
Aban Offshore receives LoA for deployment of 3 jack-up rigs in UAE - 12-Jul-2018 12:26
Larsen & Tubro wins orders worth Rs 23.88 bn - 12-Jul-2018 10:51
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer